Logo BSU

Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот документ: https://elib.bsu.by/handle/123456789/289034
Заглавие документа: Cm-dil staining and sec of plasma as an approach to increase sensitivity of extracellular nanovesicles quantification by bead-assisted flow cytometry
Авторы: Nikiforova, Nadezhda
Chumachenko, Maria
Nazarova, Inga
Zabegina, Lidia
Slyusarenko, Maria
Sidina, Elena
Malek, Anastasia
Тема: ЭБ БГУ::ЕСТЕСТВЕННЫЕ И ТОЧНЫЕ НАУКИ::Биология
Дата публикации: 2021
Издатель: MDPI AG
Библиографическое описание источника: Membr 2021;11(7).
Аннотация: The quantification of the specific disease-associated populations of circulating extracellular membrane nanovesicles (ENVs) has opened up new opportunities for liquid biopsy in cancer and other chronic diseases. However, the sensitivity of such methods is mediated by an optimal combination of the isolation and labeling approaches, and is not yet sufficient for routine clinical application. The presented study aimed to develop, characterize, and explore a new approach to non-specific ENV staining, followed by size-exclusive chromatography (SEC), which allows us to increase the sensitivity of bead-assisted flow cytometry. Plasma from healthy donors was purified from large components, stained with lipophilic CM-Dil dye, and fractionated by means of SEC. The obtained fractions were analyzed in terms of particle size and concentration using NTA, as well as vesicular markers and plasma protein content via dot-blotting. We characterized the process of CM-Dil-stained plasma fractionation in detail and indicated the fractions with optimal characteristics. Finally, we explored the sensitivity of on-bead flow cytometry for the analysis of specific populations of plasma ENVs and demonstrated the advantages and limitations of the proposed technique.
URI документа: https://elib.bsu.by/handle/123456789/289034
DOI документа: 10.3390/membranes11070526
Scopus идентификатор документа: 85111683253
Финансовая поддержка: This research was funded by the Ministry of Health of the Russian Federation in the framework of the “Development and clinical testing of methods for isolation, analysis and modification of the circulating plasma nanovesicles with the aim of personalized selection and increasing the effectiveness of standard regimens of systemic therapy for oncological diseases” project № 056-00108-21-02/121032300202-6, 2021–2023.
Лицензия: info:eu-repo/semantics/openAccess
Располагается в коллекциях:Статьи биологического факультета

Полный текст документа:
Файл Описание РазмерФормат 
membranes-11-00526.pdf2,24 MBAdobe PDFОткрыть
Показать полное описание документа Статистика Google Scholar



Все документы в Электронной библиотеке защищены авторским правом, все права сохранены.